Atlas Trials

Risk-stratification Based Bladder-sparing Modalities for Muscle-invasive Bladder Cancer

Clinical trial NCT05531123 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05531123
Sponsor
Fudan University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2022-09-10
Primary completion
2026-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.